Intrexon and Synthetic Biologics Collaborate Again
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 8 (Table of Contents)
Published: 14 Aug-2012
DOI: 10.3833/pdr.v2012.i8.1789 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Synthetic Biologics has partnered with Intrexon for a second time to develop and commercialise monoclonal antibodies for three undisclosed infectious disease indications utilising Intrexon's synthetic biology technologies...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS